HTRF Human Total TYK2 Detection Kit, 500 Assay Points

Total TYK2 assay principle

The Total-TYK2 assay quantifies the expression level of TYK2 in a cell lysate. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The Total-TYK2 assay uses two labeled antibodies: one coupled to a donor fluorophore, the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In presence of TYK2 in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the protein’s expression under a no-wash assay format.

Total TYK2 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before the addition of Total TYK2 HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

Total TYK2 1-plate assay protocol

Detection of total TYK2 with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

Phospho and Total-TYK2 (Tyr1054/1055) Inhibition on Hela cells

Hela cells (cervical cancer) were plated in 96-well culture-treated plate (200,000 cells/well) in complete culture medium, and incubated overnight at 37°C,5%CO2. Cells were treated with a dose-response of Deucravacitinib (BMS-986165) 3h at 37 °C, 5% CO2. Cells were stimulated with pervanadate 100 µM and IFN beta 1nM for 1 hour at 37°C,5%CO2. Cells were then lysed with 50 µl of supplemented lysis buffer #4 (1X) for 30 min at RT under gentle shaking. After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Phospho-TYK2 (Tyr1054/1055) or Total-TYK2 detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

As expected, Deucravacitinib induced a dose-dependent decrease of TYK2 phosphorylation, without effect on the expression level of the total protein.

Phospho and Total TYK2 (Tyr1054/1055) Inhibition on HEL92.1.7 cells

HEL92.1.7 cells (Human erythroleukaemia) were seeded in a half area 96-well culture-treated plate at 400,000 cells / well in 20 µL complete culture medium and incubated overnight. Cells were treated with 5µL of a dose-response of Deucravacitinib (BMS-986165) 3h at 37 °C, 5% CO2 then with IFN beta 1nM for 15mn at 37°C,5%CO2. Cells were then lysed with 50 µl of supplemented lysis buffer #4 (1X) for 30 min at RT under gentle shaking. After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Phospho-TYK2 (Tyr1054/1055) or Total-TYK2 detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

As expected, Deucravacitinib induced a dose-dependent decrease of TYK2 phosphorylation, without effect on the expression level of the total protein.

HTRF Total TYK2 Assay compared to Western Blot

HEL92.1.7 cells were cultured in a T175 flask in complete culture medium at 37°C, 5% CO2. After 72h incubation, the cells were lysed with 3 mL of supplemented lysis buffer #4 (1X) for 30 minutes at RT under gentle shaking.

Serial dilutions of the cell lysate were performed using supplemented lysis buffer, and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF Total-TYK2 detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot.

A side by side comparison of Western Blot and HTRF demonstrates that the HTRF assay is 8-fold more sensitive than the Western Blot, at least under these experimental conditions.

Simplified pathway of TYK2 signaling

TYK2 in combination with JAK1, JAK2, or JAK3 interacts with different types of cytokine/interferon receptors (IL2, IL23, IFN alpha and beta). Upon cytokine activation, TYK2 and the other members of the JAK family transphosphorylate each other, and then activate the transcription factors STAT1, STAT2, STAT3, and STAT6, which dimerize. They then translocate to the nucleus to trigger the transcription of genes regulating cell differentiation, proliferation, survival, and adapted immune response.